Alliance Pharma plc (LON:APH – Get Free Report) passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 40.93 ($0.51) and traded as high as GBX 49.95 ($0.63). Alliance Pharma shares last traded at GBX 46.40 ($0.58), with a volume of 943,356 shares.
Alliance Pharma Trading Down 1.8 %
The company has a market capitalization of £246.23 million, a PE ratio of -759.17, a P/E/G ratio of 1.04 and a beta of 0.67. The company has a debt-to-equity ratio of 47.46, a current ratio of 2.93 and a quick ratio of 1.42. The firm’s 50 day moving average is GBX 45.91 and its 200 day moving average is GBX 40.93.
Alliance Pharma Company Profile
Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.
Featured Articles
- Five stocks we like better than Alliance Pharma
- What Are Dividend Challengers?
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- What Are Growth Stocks and Investing in Them
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- What is the Nasdaq? Complete Overview with History
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for Alliance Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alliance Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
